Corsano Health
Revolutionizing Continuous Remote Health Monitoring

As the benefits of remote patient monitoring (RPM) grow increasingly evident, wearable devices emerge as the revolutionary reformation of health assessment. Particularly when millions of heart attacks are recorded worldwide per year, the ability to continuously track patient data with RPM devices can help physicians predict future cardiac events more accurately and offer timely, preventative therapy or treatment. Centered on this innovation, Corsano Health, a distinguished, wearable medtech company, has developed the CardioWatch 287 medical bracelet, a best-in-class, remote, vital health monitoring device.

“The CardioWatch 287 stands superior among other wearables because of its ability to provide true continuous data, at high resolution and in raw format, if desired,” says Drs. Peter C. Stas, CEO of Corsano Health. Corsano’s innovative bracelet is ergonomically designed and lightweight, forgoing a screen to ensure uninterrupted transmission of data without the wearer having to turn it on. To encourage continuous wear, the CardioWatch 287 has a battery with an extended life of 8 to 15 days.

Corsano’s CE and EU-MDR certified wearable (FDA 510K expected Q4 2022) measures far more vital parameters than any of its competitors, including heart rate, R-R intervals, ECG, SpO2, electrodermal activity, core body temperature, and photoplethysmograph (PPG) signals. Corsano’s bracelet offers continuous data acquisition and strictly complies with GDPR, ensuring high data security. “After acquiring clinically-validated data within GDPR regulations, our CardioWatch 287 transfers that data to Corsano’s certified health cloud or directly to hospital systems and platforms,” says Stas.

The therapeutic advantages of monitoring multiple vital parameters continuously with the CardioWatch 287 are numerous, as physicians are building an enormous dataset to observe pre- and post-procedures. They can assess a patient’s condition via the Corsano bracelet and promptly address issues, helping them to avoid being among the statistical onein- four readmitted within 30 days.

Researchers and physicians can also download raw data directly from the Corsano bracelet at varying frequencies of 25Hz, 32Hz, and 128Hz to build PPG curves and look for cardiovascular issues, all the while protecting the privacy of their patients.

Corsano Health is a spin-off of a watch company in Switzerland and was incorporated as the market-facing medical company in the Netherlands to enter the medtech market. Corsano works closely with some of the largest academic hospitals in Europe, including the Charité in Berlin, Germany and The Amsterdam Medical Center in The Netherlands, for improved development of its products and technology.

Revolutionizing remote patient monitoring, Corsano’s wearable device offers both intramural and extramural RPM, enabling hospitals to continuously monitor a patient, create databases of that patient data, and perform AI analysis on all cardiovascular conditions, as well as oncology-related illnesses. Corsano designed the CardioWatch 287 bracelet with an in-built API that directly pairs with the device and syncs the data with third-party applications or healthcare institutions. Priced at 100 to 250 euros, the device is extremely cost-effective.

The Corsano CardioWatch 287 bracelet proves its indispensability when it comes to the detection of atrial fibrillation (AF). A reimbursed AF Screening and Monitoring Program is running in Germany. Patients wear the Corsano bracelet on a daily basis to determine any recurrences of cardiac events and the frequency of their occurrence.

With the bracelet’s ability to provide raw data and integrated PPG algorithm to reduce false positives, Corsano recently won a bid from the Dutch Heart Foundation to develop a device that detects ‘unwitnessed cardiac arrest’ and alerts a volunteer network of 110,000. The Corsano bracelet perfectly fit the bill; able to send an alert directly to an emergency dispatch center.

It is such innovative approaches that position Corsano to provide the best-in-class remote vital health monitoring wearables.